procainamide has been researched along with Autoimmune Demyelinating Disease, Peripheral in 2 studies
Procainamide: A class Ia antiarrhythmic drug that is structurally-related to PROCAINE.
procainamide : A benzamide that is 4-aminobenzamide substituted on the amide N by a 2-(diethylamino)ethyl group. It is a pharmaceutical antiarrhythmic agent used for the medical treatment of cardiac arrhythmias.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Erdem, S | 1 |
| Freimer, ML | 1 |
| O'Dorisio, T | 1 |
| Mendell, JR | 2 |
| Sahenk, Z | 1 |
| Rossio, JL | 1 |
| Hurtubise, P | 1 |
2 other studies available for procainamide and Autoimmune Demyelinating Disease, Peripheral
| Article | Year |
|---|---|
Procainamide-induced chronic inflammatory demyelinating polyradiculoneuropathy.
Topics: Aged; Anti-Arrhythmia Agents; Chronic Disease; Demyelinating Diseases; Humans; Male; Neural Conducti | 1998 |
Polyradiculoneuropathy accompanying procainamide-induced lupus erythematosus: evidence for drug-induced enhanced sensitization to peripheral nerve myelin.
Topics: Aged; Angina Pectoris; Animals; Demyelinating Diseases; Drug Hypersensitivity; Humans; Lupus Erythem | 1977 |